 cervicovagin microflora pregnanc outcom result double-blind placebo-control trial erythromycin treatment avail inform instanc preterm birth prematur ruptur membran unrecogn infect inflamm uterin segment decidua fetal membran variou cervicovagin microorgan site mani microorgan factor fetal membran releas prostaglandin studi presenc variou genit tract microflora bacteri condit women double-blind placebo-control trial short-cours erythromycin treatment week gestat preterm birth demograph obstetr microbiolog paramet prematur ruptur membran women erythromycin versu placebo preterm prematur ruptur membran patient erythromycin versu placebo erythromycin treatment occurr prematur ruptur membran women posit chlamydia trachomati infect logist regress analysi trachomati odd vagin wash phospholipas odd prior preterm birth odd increas risk preterm birth bacteri vaginosi mycoplasma homini ureaplasma increas risk preterm birth preterm ruptur membran find role genit tract microflora preterm birth prematur ruptur larg treatment trial specif infect condit preterm birth prematur ruptur membran valu antimicrobi treatment prevent microbial-associ preterm birth